ICA Group Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
CCM
ICA Group Wealth Management's NVS Position: Q2 2024 in Review
ICA Group Wealth Management reduced its Novartis (NVS) stake by 37% in Q2 2024, selling an estimated $2.91K and leaving 50 shares worth $5.32K. The position accounts for ﹤0.01% of the portfolio, ranked #577.
ICA Group Wealth Management first reported a position in NVS in Q4 2022 and has held it in 6 quarters since. The position peaked at $10.9K in Q2 2023. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.
- ICA Group Wealth Management held 50 shares of Novartis worth $5.32K as of Q2 2024.
- ICA Group Wealth Management sold 29 Novartis shares in Q2 2024, an estimated $2.91K.
- Novartis made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #577 holding.
- ICA Group Wealth Management first reported a position in Novartis in Q4 2022 and has held it in 6 quarters since.
- ICA Group Wealth Management's Novartis position peaked at $10.9K in Q2 2023.
- 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.
Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.